ArticleEuropean journal of pediatrics2026
High prevalence of avoidant/restrictive food ıntake disorder and psychiatric comorbidities in pediatric eosinophilic esophagitis.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence and clinical correlates of avoidant/restrictive food intake disorder in children and adolescents with Celiac disease: a cross-sectional study.Journal of eating disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to evaluate the prevalence and subtypes of avoidant/restrictive food intake disorder (ARFID) as well as other psychiatric comorbidities in children and adolescents diagnosed with eosinophilic esophagitis (EoE). In this cross-sectional study, 29 children and adolescents (24 males, 82.8%) with EoE and 61 healthy controls (HC; 30 males, 49.2%) were included. The clinical group was recruited from a pediatric gastroenterology outpatient clinic, while the HC group was recruited from an outpatient child and adolescent psychiatry clinic, where participants were evaluated and found to have no psychiatric or somatic disorders after thorough assessment.All participants underwent structured diagnostic interviews. They also completed the Nine-Item Avoidant/Restrictive Food Intake Disorder Screen-Self-Report, Revised Child Anxiety and Depression Scale, and Children's Eating Attitudes Test-26, while parents completed the NIAS-Parent Report, State-Trait Anxiety Inventory-Trait and State Form, Beck Depression Inventory, and Eating Disorder Examination Questionnaire-Short Form. ARFID was observed in 70.8% of the EoE group, a significantly higher rate than in the HC group (29.2%) (p < 0.001). Among EoE patients, the picky eating and appetite subtypes were more frequent, while the fear subtype was observed only in this group. Psychiatric comorbidities were also more prevalent in participants with EoE (70.3%) compared with HC (29.7%) (p < 0.001). Attention-deficit/hyperactivity disorder (ADHD) and anxiety disorders, such as separation anxiety, social phobia, school phobia, generalized anxiety, and panic disorder, were significantly more common in EoE compared to the HC group (p < 0.05).
conclusionsChildren and adolescents diagnosed with EoE appear to have a significantly increased risk for ARFID and other psychiatric comorbidities, especially ADHD and anxiety disorders. Regular multidisciplinary follow-up, including child psychiatry involvement, is essential for comprehensive assessment and management of these patients. WHAT IS KNOWN: • Eosinophilic esophagitis (EoE) is a chronic, immune-mediated disease of the esophagus, frequently associated with feeding difficulties and restrictive eating behaviors. • Avoidant/restrictive food ıntake disorder (ARFID) is increasingly recognized in EoE, but data on its prevalence and psychiatric comorbidities in pediatric populations remain limited. WHAT IS NEW: • Children with EoE showed markedly higher rates of ARFID, attention-deficit/hyperactivity disorder, and anxiety than healthy peers. • The NIAS-PR total score showed excellent discrimination in identifying ARFID, supporting its robust clinical utility for screening in pediatric gastroenterology practice.
Indexed as
Identifiers
41896440What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.